This Nuclear Energy Stock Just Got a Big Government Boost. Should You Buy It Here?
Centrus Energy (LEU) shares inched up on Friday after the nuclear energy company secured an extension on its government contract to produce High-Assay, Low-Enriched Uranium (HALEU).
LEU's press release valued the one-year extension at about $110 million, adding that the Department of Energy (DOE) has the option to extend that contract for up to eight more years.
Dear Tesla Stock Fans, Mark Your Calendars for June 30
3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio
This Options Tool Can Show You How to Trade Tesla Stock Ahead of Robotaxi Day
Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now!
Including today's gain, Centrus Energy stock is up more than 280% versus its low set in early April.
The HALEU contract extension is rather meaningful for Centrus Energy stock as it ensures continued visibility into future revenues.
Additionally, this government extension reinforces the clean energy firm's pivotal role in restoring the country's ability to enrich uranium (UXM25) as well.
With up to eight additional years of production still on the table, the DOE deal positions LEU as a long-term strategic partner in fueling next-generation nuclear reactors.
As global interest in clean, secure energy intensifies, partly due to rapidly increasing demand from AI – Maryland-based Centrus stands to benefit from both commercial and national security-driven demand for HALEU.
That makes LEU shares more attractive for long-term growth investors.
Despite its meteoric run in recent months, Evercore ISI analysts are convinced that Centrus Energy stock has further room to the upside.
Earlier this week, the investment firm reiterated its 'Outperform' rating on the clean energy stock and raised its price target to $205, which indicates potential upside of another 8.5% from current levels.
Evercore ISI remains positive on LEU shares mostly because Centrus is the only company that the Nuclear Regulatory Commission has licensed so far for HALEU production.
According to its analysts, the U.S. must 'unleash its advanced nuclear energy' to win the AI race.
Other Wall Street analysts are nowhere near as constructive on LEU stock as Evercore ISI since it's already pricing in a lot of the good news.
While the consensus rating on Centrus Energy remains at 'Strong Buy,' the mean target of about $157 indicates potential 'downside' of as much as 17% from here.
On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Is DaVita Stock Underperforming the S&P 500?
Headquartered in Denver, Colorado, DaVita Inc. (DVA) provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $10.3 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. Companies worth $10 billion or more are generally described as 'large-cap stocks,' and DVA perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical care facilities industry. Its scale, operating over 3,000 dialysis centers nationwide, enables cost efficiencies, strong brand recognition, and a vast clinical network. DaVita benefits from long-term relationships with nephrologists and payors, including value-based care arrangements with Medicare and commercial insurers, which help stabilize revenue. The Next Trillion-Dollar Boom? 3 Stocks to Buy with 300 Million Humanoid Robots on the Horizon. Warren Buffett's Berkshire Hathaway Now Pays 5% of All Corporate Income Taxes in America Meta's Mark Zuckerberg Says the Technology They're Developing Will 'See What You See and Hear What You Hear' Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Despite its notable strength, DVA slipped 24.1% from its 52-week high of $179.60, achieved on Jan. 31. Over the past three months, DVA stock has declined 8%, underperforming the S&P 500 Index's ($SPX) 6.3% uptick during the same time frame. In 2025, DVA has plunged 8.8%, underperforming $SPX's YTD gains of 2.4%. Moreover, the stock dipped 3.6% over the past 52 weeks, trailing $SPX's 10.3% returns. To confirm the bearish trend, DVA has been trading below its 50-day and 200-day moving averages since mid-February, with slight fluctuations. On May 12, DVA shares rose marginally after reporting its Q1 results. The company reported revenue of $3.2 billion, reflecting a 5% increase compared to the same quarter last year, driven by higher treatment volumes and favorable changes in commercial mix. However, its adjusted earnings per share declined 11.5% year-over-year to $2, primarily due to increased operating expenses, including labor and supply costs. Top rival Fresenius Medical Care AG (FMS) has taken the lead over DVA, showing resilience with 39.9% gains over the past 52 weeks and a 19.9% year-to-date increase. The stock has a consensus 'Hold' rating from the eight analysts covering it, and the mean price target of $167.14 suggests a potential upside of 22.6% from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
an hour ago
- Yahoo
Hindustan Zinc champions sustainable zinc solutions at top Galvanizing Conference in Malaysia
KUALA LUMPUR, Malaysia, June 24, 2025 /PRNewswire/ -- Hindustan Zinc Limited, the world's largest integrated zinc producer, champions sustainable zinc solutions by representing India at the 13th Asia Pacific General Galvanizing Conference, hosted by the Galvanizers Association of Malaysia. Held from June 23rd to 26th at the Kuala Lumpur Convention Centre, the premier event provides a strategic platform for the company to highlight its global capabilities. Zinc plays a critical role in galvanization, protecting steel from corrosion and enabling key sectors such as infrastructure, automotive, renewable energy, electronics, defence, hi-tech manufacturing and electric mobility. Studies indicate that the cost of corrosion for Malaysia is roughly 3% of GDP. As a key integrated player in the global zinc value chain, Hindustan Zinc ensures a steady supply of transition metals worldwide. At Booth No. 10, the company's pavilion features an immersive 3D augmented reality experience, giving delegates a firsthand look at its technology-driven operations. Hindustan Zinc also led a thought leadership session titled 'Galvanizing Industries: Current Scenario and Impact', which brought together global leaders, corrosion specialists and policymakers to discuss zinc's evolving role in sustainable infrastructure. With a presence in over 40 countries, Hindustan Zinc offers a diverse portfolio of products including Special High Grade (SHG) Zinc, SHG Jumbo, Continuous Galvanizing Grade (CGG) Zinc and Zinc Die-Casting Alloys (HZDA 3 and 5). The company has also launched EcoZen, Asia's first low carbon 'green' zinc, produced using renewable energy which has a carbon footprint about 75% lower than conventional zinc. Mr. Arun Misra, CEO – Hindustan Zinc, said, "As the world moves towards cleaner energy systems, the importance of zinc is increasing at an unprecedent rate. We are proud to present our integrated operations at this global platform. With Southeast Asia's rapid growth, ensuring a reliable supply of top-quality zinc is a strategic priority." Hindustan Zinc's Customer Technical Services team and Centre of Excellence collaborate closely with customers to meet their specific needs. The company's products are ISO (International Organization for Standardization) certified for quality and EPD (Environmental Product Declaration) verified, ensuring environmental transparency. About Hindustan Zinc Limited Hindustan Zinc, a Vedanta Group company, is the world's largest integrated zinc producer and amongst the top five silver producers globally. The company has been recognized as the world's most sustainable metals & mining company by the S&P Global CSA 2024. Contact: Sonal Choithani (CCO) View original content: SOURCE Hindustan Zinc Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Is UDR Stock Underperforming the Dow?
Highlands Ranch, Colorado-based UDR, Inc. (UDR) owns, operates, acquires, develops, redevelops, renovates and manages apartment communities in high barrier-to-entry markets. With a market cap of $13.6 billion, UDR operates as one of the most favorably-positioned multi-family apartment REITs in the U.S. Companies worth $10 billion or more are generally described as "large-cap stocks." UDR fits right into that category, with its market cap exceeding the threshold, reflecting its substantial size and influence in the REIT industry. The Next Trillion-Dollar Boom? 3 Stocks to Buy with 300 Million Humanoid Robots on the Horizon. Warren Buffett's Berkshire Hathaway Now Pays 5% of All Corporate Income Taxes in America Meta's Mark Zuckerberg Says the Technology They're Developing Will 'See What You See and Hear What You Hear' Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! UDR touched its two-year high of $47.55 on Sep. 16, 2024, and is currently trading 13% below that peak. UDR stock has dropped 4.5% over the past three months, lagging behind the Dow Jones Industrial Average's ($DOWI) 1.4% gains during the same time frame. UDR stock has underperformed the Dow over the longer term as well. UDR stock prices have dropped 4.7% on a YTD basis and inched up 1.7% over the past 52 weeks, lagging behind Dow's marginal uptick in 2025 and 8.8% gains over the past year. UDR has traded mostly below its 50-day and 200-day moving averages since early April with some fluctuations, underscoring its recent downturn. UDR stock prices gained 1.7% in the trading session after the release of its resilient Q1 results on Apr. 30. The company experienced high demand for its apartment house, leading to a 2.6% year-over-year growth in comparable same-store sales and a 2.8% increase in comparable net operating income. Its overall topline for the quarter increased slightly more than 2% year-over-year to approximately $422 million. Meanwhile, its adjusted funds from operations (AFFO) observed a marginal 63 bps growth to $219.1 million, and its AFFO per share of $0.61 matched the Street's expectations. While UDR has underperformed its peer Invitation Homes Inc.'s (INVH) 6.4% gains in 2025, it has outperformed INVH's 4% decline over the past 52 weeks. Among the 24 analysts covering the UDR stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $46.29 suggests an 11.8% upside potential from current price levels. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
